Stock Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh by November 8, 2024 written by November 8, 2024 Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com 0 comment 0 FacebookTwitterPinterestEmail previous post Richemont shares fall amid sluggish China demand, margin pressures next post Richemont remains cautious on raising jewellery prices despite high gold prices You may also like Adani’s Australian coal unit faces human rights complaint November 22, 2024 S&P lowers outlook on three Adani units after... November 22, 2024 Australia stocks higher at close of trade; S&P/ASX... November 22, 2024 F1, ESPN open talks over next US media... November 22, 2024 Advance Magazine seeks credit facility using $1.2 bln... November 22, 2024 Morgan Stanley opens new Southeast Asia headquarters in... November 22, 2024 OpenAI considers developing web browser to take on... November 22, 2024 Trump considers Warsh for Treasury Secretary and later... November 22, 2024 DirecTV terminates Dish deal over failed debt swap November 22, 2024 Asia stocks rise as chips, cyclical gains help... November 22, 2024